Usefulness of Transcatheter Aortic Valve Implantation for Treatment of Pure Native Aortic Valve Regurgitation

Ole De Backer, Thomas Pilgrim, Matheus Simonato, G. Burkhard Mackensen, Claudia Fiorina, Verena Veulemanns, Alfredo Cerillo, Joachim Schofer, Nicolas Amabile, Guy Achkouty, Ulrich Schäfer, Marcus André Deutsch, Jan Malte Sinning, Mohammed S. Rahman, Fadi J. Sawaya, David Hildick-Smith, Jose Maria Hernandez, Won Keun Kim, Thierry Lefevre, Moritz SeiffertSabine Bleiziffer, Anna Sonia Petronio, Nicolas Van Mieghem, Maurizio Taramasso, Lars Søndergaard, Stephan Windecker, Azeem Latib, Danny Dvir

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

Patients with pure native aortic valve regurgitation (NAVR) and increased surgical risk are often denied surgery. This retrospective study aimed to evaluate the “off-label” use of transcatheter heart valves (THV) for the treatment of NAVR. A total of 254 high surgical risk patients with NAVR (age 74 ± 12 years, Society of Thoracic Surgeons risk score 6.6 ± 6.2%) underwent transcatheter aortic valve implantation (TAVI) with early generation (43%) or newer generation (57%) devices at 46 different sites. Device success was significantly higher in patients treated with newer as compared with early generation THV (82% vs 47%, p <0.001). The difference was driven by lower rates of device malpositioning (9% vs 33%) and aortic regurgitation (AR) ≥ moderate (4% vs 31%) and translated into higher clinical efficacy at 30 days in patients treated with newer as compared with early generation THV (72% vs 56%, p = 0.041). Both THV under- and oversizing were associated with an increased risk of THV malpositioning. In conclusion, TAVI is a feasible treatment strategy in selected high-risk patients with NAVR but is associated with a considerable risk of THV malpositioning and residual AR. Although newer-generation THV are associated with better outcomes, novel devices for the treatment of NAVR are warranted.

Original languageEnglish (US)
Pages (from-to)1028-1035
Number of pages8
JournalAmerican Journal of Cardiology
Volume122
Issue number6
DOIs
StatePublished - Sep 15 2018
Externally publishedYes

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Usefulness of Transcatheter Aortic Valve Implantation for Treatment of Pure Native Aortic Valve Regurgitation'. Together they form a unique fingerprint.

Cite this